Epocrates - About the company
Epocrates is an acquired company based in San Mateo (United States), founded in 1998 by Richard Fiedotin. It operates as a Clinical decision support tool providing continually updated medical content for clinicians. Epocrates has raised $35M in funding, with last known valuation of $*****. The company has 137 active competitors, including 24 funded and 17 that have exited. Its top competitors include companies like Memed, Eon and ProVation Medical.
Company Details
Clinical decision support tool providing continually updated medical content for clinicians. It offers essential, researched, and updated clinical content to healthcare professionals. The platform delivers in-depth clinical information, enabling providers to prescribe safely and efficiently at the point of care. It is a software solution designed to be a reliable resource for medical professionals, offering features that support informed decision-making. The company focuses on providing accurate and condensed data, ensuring clinicians have access to trusted information. It is a B2B tech company offering a valuable tool for modern medical practice, enhancing patient care through accessible and reliable medical knowledge.
Key Metrics
Founded Year
1998
Location
San Mateo, United States
Stage
Acquired
Total Funding
$35M in 2 rounds
Latest Funding Round
Last Known Valuation
$***** as on Jan 07, 2013
Investors
Ranked
3rd among 137 active competitors
Annual Revenue
$100M - $500M as on Dec 31, 2012
Employee Count
10 - 49 as on Mar 01, 2026
Exit Details
Acquired by athenahealth (Jan 07, 2013)
Legal entities associated with Epocrates
Epocrates is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
Epocrates Inc CIN: 1096738 , United States, Active | Jul 10, 1986 | $100M - $500M (As on Dec 31, 2012) | - | - |
Epocrates, LLC CIN: 943326769 , United States, Active | Nov 16, 2005 | - | 417 (As on Dec 31, 2022) | - |
Epocrates's acquisition details
Epocrates got acquired by athenahealth on Jan 07, 2013 at an acquisition amount of $*****.
Click here to take a look at Epocrates's acquisition in detail
Sign up to download Epocrates' company profile
Epocrates's funding and investors
Epocrates has raised a total funding of $35M over 2 rounds. Its first funding round was on Aug 20, 2000. Its latest funding round was a Series C round on Aug 19, 2002 for $*****. 4 investors participated in its latest round. Epocrates has 10 institutional investors.
Here is the list of recent funding rounds of Epocrates:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Aug 19, 2002 | 3780177 | Series C | 2783629 | 1449153 | 5034693 | 1635688 |
Aug 20, 2000 | 5514971 | Series B | 1849043 | 8350428 | 6114422 |
View details of Epocrates's funding rounds and investors
Epocrates' founders and board of directors
Founder? Claim ProfileThe founders of Epocrates is Richard Fiedotin.
Here are the details of Epocrates' key team members:
- Richard Fiedotin: Co-Founder of Epocrates.
View details of Epocrates's Founder profiles and Board Members
Epocrates' employee count trend
Epocrates has 10 - 49 employees as of Mar 26. Here is Epocrates's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Epocrates's Competitors and alternates
Top competitors of Epocrates include Memed, Eon and ProVation Medical. Here is the list of Top 10 competitors of Epocrates, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Application with curated drug information used by physicians | $97.9M | 57/100 | ||
2nd | Eon 2014, Denver (United States), Series B | Provider of patient management software | $22M | 56/100 | |
3rd | Epocrates 1998, San Mateo (United States), Acquired | Clinical decision support tool providing continually updated medical content for clinicians | $35M | 52/100 | |
4th | ProVation Medical 1994, Minneapolis (United States), Acquired | Clinical documentation and workflow automation solutions improving healthcare quality | $14.5M | 53/100 | |
5th | Provider of medical data analysis platform to enhance the healthcare system | $8.34M | 52/100 | ||
6th | MMIT Network 1994, Yardley (United States), Acquired | Provider of data, analytics, and software for pharmaceutical and healthcare sectors | $27.4M | 46/100 | |
7th | Stabl 2021, Dallas (United States), Acquired | Digital patient treatment planning tool for healthcare professionals | - | 44/100 | |
8th | AgileMD 2011, San Francisco (United States), Seed | AI-powered clinical decision support for better healthcare outcomes and efficiency | $2M | 44/100 | |
9th | Medicomp 1978, Chantilly (United States), Funding Raised | Diagnostically connecting data to improve patient outcomes and empower healthcare providers | - | - | 43/100 |
10th | Decisio Health 2013, Houston (United States), Acquired | Clinical intelligence platform transforming data into actionable insights for better healthcare | $35.4M | 42/100 |
Looking for more details on Epocrates's competitors? Click here to see the top ones
Epocrates's Investments and acquisitions
Epocrates has made no investments or acquisitions yet.
Reports related to Epocrates
Here is the latest report on Epocrates's sector:
News related to Epocrates
Media has covered Epocrates for 1 event in last 1 year, It was about partnerships.
•
epocrates Partners with ScriptSave to Integrate Real-Time Prescription Pricing into Clinician WorkflowsBusiness Wire•Sep 23, 2026•ScriptSave, Epocrates
•
athenahealth Appoints David Minkin General Manager of epocratesHIT Consultant•Feb 06, 2024•athenahealth, Epocrates
•
athenahealth Names David Minkin General Manager of epocratesBusiness Wire•Feb 06, 2024•athenahealth, Epocrates
•
epocrates and Cognito Therapeutics Join Forces to Deliver Video Messaging to Healthcare ProfessionalsTullahoma News•Apr 27, 2023•Epocrates, Cognito Therapeutics
•
epocrates Celebrates Sizable 2022 Growth, Driven by New Design, Tools, and Guidelines to Improve the Clinician ExperienceBusiness Wire•Mar 02, 2023•Epocrates
•
epocrates Launches Bugs + Drugs Tool to Promote Optimal Antibiotic Prescribing Amid Healthcare’s Growing Antimicrobial Resistance CrisisBusiness Wire•Sep 07, 2022•Epocrates
•
epocrates Appoints New Leaders to Guide Commercial Strategy, Consulting, and Customer Experience Amidst New Wave of GrowthBusiness Wire•Jun 15, 2022•Epocrates, athenahealth, Wiley Education Services
•
•
epocrates Unveils Redesigned Mobile App to Streamline Access to Clinician ToolsBusiness Wire•May 10, 2022•Epocrates
•
epocrates Closes Successful 2021 Marked by Accelerated Growth, New Offerings, and Innovative PartnershipsBusiness Wire•Dec 16, 2021•Epocrates
Are you a Founder ?
FAQs about Epocrates
Explore our recently published companies
- Livingwaters.in - India based, 2022 founded, Unfunded company
- cuRevive - India based, 2026 founded, Unfunded company
- Automind Dynamics - Bengaluru based, 2025 founded, Unfunded company
- Spolyn - Sonipat based, 2025 founded, Unfunded company
- DARCA - Lithuania based, 2024 founded, Unfunded company
- CSJ Plasmasys - Kolkata based, 2022 founded, Unfunded company